Skip to main content
Smart Investors Daily
GR

NYSE · GRX

The Gabelli Healthcare & Wellness Trust

Financial Services · Asset Management

$10.28

Up+$0.13 (+1.26%)

Updated Nov 4, 2026, 10:46 PM

SID Score

4.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
151.54M
P/E ratio
-215.13
Dividend yield
7.88%
52-week range
$8.80 – $10.29
Volume
32.72K
Avg. volume
34.22K

Price performance · GRX

GRX price history

1M range · 0 trading sessions · Daily adjusted prices

GRX does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest GRX news

The latest Smart Investors Daily articles mentioning GRX.

GRX research

Overview

Company profile and research snapshot.

Company profile

Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

seekingalpha.com · Nov 14, 2025

Gabelli Healthcare & Wellness Trust Q3 2025 Commentary

Gabelli Healthcare & WellnessRx Trust is a diversified, closed-end management investment company whose investment objective is long-term growth of capital. Healthcare stocks rose during the quarter but continued to lag the broader stock market. On the consumer side, the food industry continued to face headwinds from the cumulative effect of inflation on consumer spending as well as lower consumption due to widespread adoption of GLP-1 weight loss.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.